Magnetic resonance imaging of cholesteatoma: an update
J. Ph. Vercruysse*, B. De Foer**, Th. Somers*, J. Casselman***** and E. Offeciers*
*University Department of ENT, **Department of Radiology, A.Z. Sint-Augustinus Hospital, Antwerp, Belgium; ***Department of Radiology, A.Z. Sint-Jan AV, Bruges, Belgium
Cholesteatoma; middle ear; diffusion-weighted MRI; computed tomography
233 - 240
Magnetic resonance imaging of cholesteatoma: an update. Objective: To report on the value and limitations of new MRI techniques in pre- and post-operative MRI of cholesteatoma. The current value of magnetic resonance imaging (MRI) in diagnosing congenital, acquired, and post-operative recurrent or residual cholesteatoma is described. Methodology and results: High resolution computed tomography (HRCT) is still considered the imaging modality of choice for detecting acquired or congenital middle ear cholesteatoma. However, MRI may provide additional information on the delineation and extension of cholesteatoma and on potential complications. Detecting post-operative residual or recurrent cholesteatoma with HRCT was shown to be inaccurate due to the technique’s low sensitivity and specificity. Conclusions: Recently, improvements in MRI techniques have led to a more accurate diagnoses of cholesteatoma using delayed contrast enhanced T1-weighted imaging and diffusion-weighted imaging.
Vol. 5, 2009, 4th trimester

Magnetic resonance imaging of cholesteatoma: an update